Literature DB >> 26193819

Using decision lists to construct interpretable and parsimonious treatment regimes.

Yichi Zhang1, Eric B Laber1, Anastasios Tsiatis1, Marie Davidian1.   

Abstract

A treatment regime formalizes personalized medicine as a function from individual patient characteristics to a recommended treatment. A high-quality treatment regime can improve patient outcomes while reducing cost, resource consumption, and treatment burden. Thus, there is tremendous interest in estimating treatment regimes from observational and randomized studies. However, the development of treatment regimes for application in clinical practice requires the long-term, joint effort of statisticians and clinical scientists. In this collaborative process, the statistician must integrate clinical science into the statistical models underlying a treatment regime and the clinician must scrutinize the estimated treatment regime for scientific validity. To facilitate meaningful information exchange, it is important that estimated treatment regimes be interpretable in a subject-matter context. We propose a simple, yet flexible class of treatment regimes whose members are representable as a short list of if-then statements. Regimes in this class are immediately interpretable and are therefore an appealing choice for broad application in practice. We derive a robust estimator of the optimal regime within this class and demonstrate its finite sample performance using simulation experiments. The proposed method is illustrated with data from two clinical trials.
© 2015, The International Biometric Society.

Entities:  

Keywords:  Decision lists; Exploratory analyses; Interpretability; Personalized medicine; Treatment regimes

Mesh:

Year:  2015        PMID: 26193819      PMCID: PMC4715597          DOI: 10.1111/biom.12354

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  24 in total

1.  Estimation and extrapolation of optimal treatment and testing strategies.

Authors:  James Robins; Liliana Orellana; Andrea Rotnitzky
Journal:  Stat Med       Date:  2008-10-15       Impact factor: 2.373

2.  Doubly Robust Learning for Estimating Individualized Treatment with Censored Data.

Authors:  Y Q Zhao; D Zeng; E B Laber; R Song; M Yuan; M R Kosorok
Journal:  Biometrika       Date:  2015-03-01       Impact factor: 2.445

3.  Reinforcement learning design for cancer clinical trials.

Authors:  Yufan Zhao; Michael R Kosorok; Donglin Zeng
Journal:  Stat Med       Date:  2009-11-20       Impact factor: 2.373

4.  Representation of clinical practice guidelines in conventional and augmented decision tables.

Authors:  R N Shiffman
Journal:  J Am Med Inform Assoc       Date:  1997 Sep-Oct       Impact factor: 4.497

Review 5.  Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.

Authors:  M H Gail; J P Costantino; J Bryant; R Croyle; L Freedman; K Helzlsouer; V Vogel
Journal:  J Natl Cancer Inst       Date:  1999-11-03       Impact factor: 13.506

6.  PERFORMANCE GUARANTEES FOR INDIVIDUALIZED TREATMENT RULES.

Authors:  Min Qian; Susan A Murphy
Journal:  Ann Stat       Date:  2011-04-01       Impact factor: 4.028

7.  Q-learning for estimating optimal dynamic treatment rules from observational data.

Authors:  Erica E M Moodie; Bibhas Chakraborty; Michael S Kramer
Journal:  Can J Stat       Date:  2012-11-07       Impact factor: 0.875

8.  A multiple imputation strategy for sequential multiple assignment randomized trials.

Authors:  Susan M Shortreed; Eric Laber; T Scott Stroup; Joelle Pineau; Susan A Murphy
Journal:  Stat Med       Date:  2014-06-11       Impact factor: 2.373

9.  Estimating Optimal Treatment Regimes from a Classification Perspective.

Authors:  Baqun Zhang; Anastasios A Tsiatis; Marie Davidian; Min Zhang; Eric Laber
Journal:  Stat       Date:  2012-01-01

10.  Reader reaction to "a robust method for estimating optimal treatment regimes" by Zhang et al. (2012).

Authors:  Jeremy M G Taylor; Wenting Cheng; Jared C Foster
Journal:  Biometrics       Date:  2014-09-16       Impact factor: 2.571

View more
  23 in total

1.  Assessing the incremental value of new biomarkers based on OR rules.

Authors:  Lu Wang; Alexander R Luedtke; Ying Huang
Journal:  Biostatistics       Date:  2020-07-01       Impact factor: 5.899

2.  Efficient augmentation and relaxation learning for individualized treatment rules using observational data.

Authors:  Ying-Qi Zhao; Eric B Laber; Yang Ning; Sumona Saha; Bruce E Sands
Journal:  J Mach Learn Res       Date:  2019       Impact factor: 3.654

3.  Comparing cluster-level dynamic treatment regimens using sequential, multiple assignment, randomized trials: Regression estimation and sample size considerations.

Authors:  Timothy NeCamp; Amy Kilbourne; Daniel Almirall
Journal:  Stat Methods Med Res       Date:  2017-06-19       Impact factor: 3.021

4.  Comment.

Authors:  Qian Guan; Eric B Laber; Brian J Reich
Journal:  J Am Stat Assoc       Date:  2016-10-18       Impact factor: 5.033

5.  ON TESTING CONDITIONAL QUALITATIVE TREATMENT EFFECTS.

Authors:  Chengchun Shi; Rui Song; Wenbin Lu
Journal:  Ann Stat       Date:  2019-05-21       Impact factor: 4.028

6.  Greedy outcome weighted tree learning of optimal personalized treatment rules.

Authors:  Ruoqing Zhu; Ying-Qi Zhao; Guanhua Chen; Shuangge Ma; Hongyu Zhao
Journal:  Biometrics       Date:  2016-10-04       Impact factor: 2.571

7.  Identifying optimal level-of-care placement decisions for adolescent substance use treatment.

Authors:  Denis Agniel; Daniel Almirall; Q Burkhart; Sean Grant; Sarah B Hunter; Eric R Pedersen; Rajeev Ramchand; Beth Ann Griffin
Journal:  Drug Alcohol Depend       Date:  2020-04-28       Impact factor: 4.492

8.  Decision making and uncertainty quantification for individualized treatments using Bayesian Additive Regression Trees.

Authors:  Brent R Logan; Rodney Sparapani; Robert E McCulloch; Purushottam W Laud
Journal:  Stat Methods Med Res       Date:  2017-12-18       Impact factor: 3.021

9.  Identifying optimal dosage regimes under safety constraints: An application to long term opioid treatment of chronic pain.

Authors:  Eric B Laber; Fan Wu; Catherine Munera; Ilya Lipkovich; Salvatore Colucci; Steve Ripa
Journal:  Stat Med       Date:  2018-02-21       Impact factor: 2.373

10.  An interpretable health behavioral intervention policy for mobile device users.

Authors:  X Hu; P-Y S Hsueh; C-H Chen; K M Diaz; F E Parsons; I Ensari; M Qian; Y-K K Cheung
Journal:  IBM J Res Dev       Date:  2018-01-25       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.